Results 21 to 30 of about 70,385 (287)

Case Report: Delayed Guillain-Barré syndrome following trauma: A case series and manage considerations

open access: yesFrontiers in Surgery, 2022
AimTo analyze clinical associations between Guillain-Barré syndrome (GBS) and trauma.Material and MethodsWe retrospectively reviewed the data of eight patients with post-traumatic GBS between July 2011 and December 2018 at the Second Xiangya Hospital ...
Yiliu Zhang   +3 more
doaj   +1 more source

Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more [PDF]

open access: yes, 2012
B cells and antibodies constitute an important element in different inflammatory diseases of the central nervous system (CNS). Autoantibodies can serve as a biomarker to identify disease subgroups and may in addition contribute to the pathogenic process.
Mayer, Marie Cathrin   +5 more
core   +1 more source

Central nervous system Cryptococcoma mimicking demyelinating disease: a case report

open access: yesBMC Neurology, 2020
Background Cerebral cryptococcomas is a rare form of central nervous system cryptococcosis. Most previous cases were mistaken for neoplasm before surgery.
Jie Wei, Xiang-Yu Li, Yue Zhang
doaj   +1 more source

MR Images, Brain Lesions, and Deep Learning

open access: yesApplied Sciences, 2021
Medical brain image analysis is a necessary step in computer-assisted/computer-aided diagnosis (CAD) systems. Advancements in both hardware and software in the past few years have led to improved segmentation and classification of various diseases.
Darwin Castillo   +2 more
doaj   +1 more source

Demyelinating diseases [PDF]

open access: yesJournal of Clinical Pathology, 2006
A diagnosis of demyelination carries important therapeutic and prognostic implications. In most cases the diagnosis is made clinically, and involvement of the histopathologist is largely confined to postmortem confirmation and clinicopathological correlation.
openaire   +3 more sources

That Wasn't a Complement-Too Much C3 in Demyelinating Disease. [PDF]

open access: yesImmunity, 2020
Multiple sclerosis is a chronic inflammatory disease characterized by demyelination in the central nervous system. In this issue of Immunity, Werneberg et al.
Xin W, Chan JR.
europepmc   +2 more sources

Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18kDa Translocator Protein Radioligand [18F]DPA-714 [PDF]

open access: yes, 2012
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Activated microglia/macrophages play a key role in the immunopathogenesis of MS and its corresponding animal models, experimental autoimmune encephalomyelitis (EAE).
Thézé, Benoit   +8 more
core   +1 more source

Paediatric UK demyelinating disease longitudinal study (PUDDLS) [PDF]

open access: yes, 2011
BACKGROUND: There is evidence that at least 5% of Multiple sclerosis (MS) cases manifest in childhood. Children with MS present with a demyelinating episode involving single or multiple symptoms prior to developing a second event (usually within two ...
Roxanna Gunny   +29 more
core   +2 more sources

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease [PDF]

open access: yes, 2013
In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting.
Mathis, Johannes   +17 more
core   +1 more source

Demyelination in rheumatic diseases [PDF]

open access: yesPostgraduate Medical Journal, 2008
Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised by multifocal areas of demyelination in the white matter of the brain and spinal cord. Autoantibodies, for example antinuclear antibodies, can also be present.
A, Theodoridou, L, Settas
openaire   +3 more sources

Home - About - Disclaimer - Privacy